The Global T1D Burden of Illness Nears $100B
A 2020 white paper sponsored by the T1D Fund and Breakthrough T1D (formerly known as JDRF) showcases the vital need for novel therapies within With a global prevalence of and few approved disease modifying therapies, the impact is vast where there continues to be a need for more investment in new modalities and tools for T1D to catalyze a cure.